Tianjin Chase Sun Pharmaceutical Co.,Ltd
SHZ: 300026.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Wu Jun Lan
- Employees
- 5,297
- Headquarters
- Tianjin, China
- IPO year
- 2009
- Market cap
- CN¥10.3B
- Website
- https://www.chasesun.cn
Loading 300026…
Loading profile data…Frequently asked questions about 300026
What does Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) do?
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet based therapy. It is also involved in the research and deve...
Where does 300026.SZ trade?
Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300026.SZ in?
Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Tianjin Chase Sun Pharmaceutical Co.,Ltd?
Wu Jun Lan is the chief executive officer of Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ).
Where is Tianjin Chase Sun Pharmaceutical Co.,Ltd headquartered?
Tianjin Chase Sun Pharmaceutical Co.,Ltd is headquartered in China.
Does 300026.SZ pay a dividend?
Yes — Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) paid a trailing twelve-month dividend of CNY 0.03 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300026.SZ go public?
Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) completed its initial public offering in 2009.